In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Wendy M KittleDepartment of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40292, USA.ORCID 0000-0003-4546-2930 Micaela A HendersonDepartment of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40292, USA.
Noel Verjan GarciaCenter for Predictive Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA.
Hong LiBrown Cancer Center, School of Medicine, University of Louisville, Louisville, KY 40202, USA.ORCID 0000-0001-6362-2745 Katarina L MayerDepartment of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40292, USA.ORCID 0000-0003-2922-9151 Jimmy F Cifuentes JimenezDepartment of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40292, USA.
Kelly M LeeDepartment of Chemical Engineering, JB Speed School of Engineering, University of Louisville, Louisville, KY 40292, USA.ORCID 0009-0006-1460-160X Kavitha YaddanapudiBrown Cancer Center, School of Medicine, University of Louisville, Louisville, KY 40202, USA.ORCID 0000-0003-1186-4587 Nobuyuki MatobaDepartment of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40292, USA.ORCID 0000-0001-7231-3004 Funding
Synthesis of the library of heparan sulfate hexasaccharide mimeticsR44GM145004 · NIGMS · GLYCAN THERAPEUTICS CORPORATION · PI SU, GUOWEI · 2023 to 2025
$2.4MPreclinical validation of oral therapeutic lead proteins targeting epithelial GM1 ganglioside for ulcerative colitis therapyR01DK123712 · NIDDK · UNIVERSITY OF LOUISVILLE · PI MATOBA, NOBUYUKI · 2020 to 2023
$1.8MNIDDK NIH HHS R01 DK123712NIGMS NIH HHS R44 GM145004NIH HHS 5R01DK123712-04
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
biotherapeuticCyTOFEPICERTINepithelial restitutionimaging mass cytometryInflammatory bowel diseasemucosal healingoxazolone colitispreclinical efficacyulcerative colitis
Identifiers
PMID42652159
PMCPMC13509488
What Socratic holds
Textmetadata
Read underepoch 390